Can you use niacinamide with salicylic acid?

No trial tests this pair on its own

The bottom line is that we found no head-to-head or placebo-controlled trial of niacinamide plus salicylic acid alone. Every study we could find used a multi-ingredient product, so any result belongs to the whole formula.

We also found no statement from the AAD, AASM, ACOG, FDA, or NIH on this combination. That leaves product trials as the only evidence, and they have gaps.

• No randomized trial tests the pair without other actives.
• No study compares the pair with either ingredient alone.
• Concentrations are missing from most trials we could access.
• Most trials run 15 days to six weeks, so long-term tolerability is largely unknown.

The split-face trial: promising, but small and sponsored

The newest study is a 16-person split-face trial. One side of each face got a product with salicylic acid, niacinamide, zinc, and pomegranate extract, and the other side was left untreated for 15 days (split-face trial, PMC; PubMed record).

The authors reported a significant drop in inflammation (p<0.001). The study was exploratory, and the product is made by La Roche-Posay, so weigh that manufacturer link.

Most participants said their skin looked better (94%), and 88% said visible lesions improved. Those are self-reported numbers from a 15-day window, so treat them as a starting signal (same trial, subjective outcomes).

Adding it to adapalene: a bigger trial with mixed results

A multicenter trial from Indonesia compared the same salicylic acid, niacinamide, and zinc cream with a placebo cream. Both groups also used adapalene 0.1% for six weeks (Indonesian adjunct trial).

Non-inflammatory lesion reduction was greater with the combination, but only in the first two weeks. We saw no difference for inflammatory lesions.

Secondhand and multi-target data: suggestive, not decisive

A review of dermocosmetic use in Australia and New Zealand describes a double-blind trial of 100 patients. A salicylic acid, niacinamide, and thermal-water product reduced the benzoyl peroxide needed to match benzoyl peroxide alone. We could not retrieve the original paper, so treat those details as unverified (regional review).

A 30-day regimen with salicylic acid, prebiotics, and zinc PCA reduced sebum, lesion counts, and redness. The authors credit the sebum effect to niacinamide and zinc PCA, but the study did not isolate niacinamide (30-day trial).

What the systematic evidence says about each ingredient

The Cochrane review found evidence for topical salicylic acid and for nicotinamide alone to be limited. Its supporting analyses were rated low quality because of imprecision (Cochrane review).

Niacinamide has an indirect signal. A systematic overview notes a 41-person trial in which niacinamide reduced sebum, though it gives no arm details (systematic overview).

In a double-blind trial, 5% niacinamide with 2.5% benzoyl peroxide cut non-inflammatory lesions by 51%, versus 34% for the vehicle base. That trial had no salicylic acid arm, so it supports niacinamide only indirectly (niacinamide with benzoyl peroxide trial). For more on the ingredient itself, see our niacinamide explainer.

The cosmeceutical review ranks retinol, benzoyl peroxide, and azelaic acid as strongest in human trials. It gives no grade to niacinamide plus salicylic acid (cosmeceutical review).